Parkinson Society Canada is conducting a patient and caregiver survey to better understand the perceived need and desire for the Parkinson’s drug called NEUPRO®which is delivered in the form of a slow-release epidermal patch. The survey will also probe individual experiences with this treatment for those who have used NEUPRO®.
The NEUPRO® patch is a dopamine agonist indicated for the treatment of Parkinson’s disease and restless legs syndrome. It works by delivering a steady stream of Parkinson’s medication over a 24 hour period through the surface of your skin, diminishing the need for dosing throughout the day like many other effective Parkinson’s drugs.
Our findings will be used to inform our Patient Evidence Submission at the federal level to the Canadian Agency for Drugs and Technology in Health (CADTH) and will be used to aide in the development of public policy and program priorities for the future.
Your feedback is extremely important and may help to improve access to this new drug for people living with PD. You do not have to be a Canadian resident to respond to this survey, and we appreciate input from every individual living with Parkinson’s disease and their caregivers.
Click on this link to begin the survey now: https://www.surveymonkey.com/s/PSC_Neupro_Survey